The Pfizer relationship is very positive and OBJ already has established a strong working relationship with the Company that could follow a similar pathway to that initiated with P&G in 2014.
Only two things happened with P&G in 2014. Multi-product PDA with first license in April, and Product launch in September. With any luck Pfizer will skip the soft launch and two year wait before global rollout, and will try to catch up to P&G. Looking forward to the Pfizer relationship.
The Pfizer relationship is very positive and OBJ already has...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add WFL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable